The Safety and Efficacy Study of HU-014 Versus Botox® in Subject With Moderate to Severe Glabellar Lines
PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment
57
Participants
Timeline
Start Date
September 30, 2016
Primary Completion Date
February 28, 2017
Study Completion Date
March 31, 2017
Conditions
Glabellar Lines
Interventions
BIOLOGICAL
HU-014 Inj
Clostridium botulinum type A
BIOLOGICAL
Botox Inj
Clostridium botulinum type A
Trial Locations (1)
13486
Huons, Seongnam-si
All Listed Sponsors
lead
Huons Co., Ltd.
INDUSTRY
NCT02961673 - The Safety and Efficacy Study of HU-014 Versus Botox® in Subject With Moderate to Severe Glabellar Lines | Biotech Hunter | Biotech Hunter